Clinical Trial Update: Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303) [Phase 4]

View source ↗

Summary

A Phase 4 study in chronic hepatitis C genotype 1 patients with insulin resistance evaluating prolonged treatment duration in late responders; the study was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Insulin Resistance

Drugs mentioned

• MK-4031

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Insulin Resistance | Phase 4 | Status: TERMINATED | Results posted: 2011-02-09